Praise be to God for this continuous blessing! I am incredibly delighted to announce that my second scientific paper has been officially accepted for publication in the journal Cardio-Oncology.
Bridging Diabetes and Cancer Care
This research represents a significant step forward in understanding the protective measures we can take for patients facing the dual challenges of cancer treatment and cardiovascular risk.
The Research Focus: Our study, titled "Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: A Systematic Review and Meta-Analysis," explores how specific medications can mitigate heart damage during intensive chemotherapy.
Methodological Rigor: As a Systematic Review and Meta-Analysis, this work synthesizes existing global data to provide high-level evidence for clinical decision-making.
Impactful Collaboration: I am honored to have co-authored this submission, contributing my expertise in pharmacotherapy and data analysis to a project that holds real-world clinical implications for patient safety.
A Foundation of Research Mastery
The acceptance of this second paper is the result of a dedicated journey toward scientific mastery throughout 2025:
Statistical Expertise: The data synthesis required for this meta-analysis was built on the same principles I recently shared as a speaker at the PSA Research Lab Workshop, where I taught students about statistics, tables, and figures for clear research.
Evolving Impact: Following the success of my first publication on RSV vaccine acceptance, this transition into Cardio-Oncology aligns with my recent abstract acceptance for the ESC Congress 2025 in Madrid.
Metric Milestones: This publication will further contribute to my growing academic footprint, building upon my recent entry into the H-index world.
Mentorship and Quality Assurance
This achievement reflects the high standards of academic quality I have championed this year, from my role as Scientific Head of the CSU Educational Program to my training in the NAQAAE Quality Assurance initiative. I am grateful to my co-authors and the mentors at Mansoura University who continue to support my path as a "Game Changer" in the field of clinical pharmacy.
"Praise be to God, a blessed and good praise ❤️ 2nd Paper acceptance ❤️" — December 3, 2025